StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $8.74 | $8.64 | -1.14% | 0.9M |
| 05-18 | $8.52 | $8.78 | +3.05% | 1.2M |
| 05-19 | $8.88 | $8.92 | +0.45% | 1.4M |
| 05-20 | $9.01 | $8.94 | -0.78% | 1.1M |
| 05-21 | $9.05 | $9.66 | +6.74% | 2.1M |
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
REalloys Inc is an integrated company focused on the development and production of rare earth elements, with a primary assets.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $706.00K | $0.00 |
Operating Income | $-87.66M | $-867.00K |
Net Income | $-106.72M | $-1.74M |
EPS (Diluted) | $-1.98 | $-0.05 |
Total Assets | $130.46M | $10.24M |
Total Liabilities | $28.89M | Not available |
Cash & Equivalents | $50.05M | $603.00K |
Free Cash Flow OCF − CapEx | $-10.55M | $-352.00K |
Shares Outstanding | 61.21M | 3.60M |
No sell-side coverage available for ALOY yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
ALOY is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.